Elicera Therapeutics Competitors and Similar CompaniesClear all
Elicera Therapeutics's competitors and similar companies include Novadip Biosciences, Cell Genesys, Vitrolife and Annexon Biosciences.
 Elicera Therapeutics Elicera Therapeutics is a clinical-stage immuno-oncology company that develops cell and gene therapies for immune-based cancer treatments. |  Cell Genesys Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today. |  Vitrolife Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. |  Annexon Biosciences Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. | ||
Founding Date | Founding Date 2014 | Founding Date 2013 | Founding Date 1988 | Founding Date 1981 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Mont-Saint-Guibert, BE HQ | Locations Roosevelt, US HQ | Locations Västra Frölunda, SE HQ | Locations Brisbane, US HQ |
Employees | Employees N/A | Employees 542% increase | Employees 89 | Employees 1,150 | Employees 10041% increase |
Valuation ($) | Valuation ($) 6.7 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 3.1 b | Valuation ($) 799.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) kr3.4b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods kr1.3b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit kr10.9m (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit kr2.2b (FY, 2025) | Gross profit N/A |
Net income | Net income (kr17.4m) (FY, 2025) | Net income N/A | Net income N/A | Net income (kr5b) (FY, 2025) | Net income ($206.7m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 31.3m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 179m |
For sources of this data, please see the company profile
View Company Profiles
Novadip Biosciences
HQ
Mont-Saint-Guibert, BE
Employees
54↑ 2% increase
Novadip Biosciences is a biopharmaceutical company.
View companyCell Genesys
HQ
Roosevelt, US
Employees
89
Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today.
View companyVitrolife
HQ
Västra Frölunda, SE
Employees
1,150
Vitrolife is a biotechnology company that develops products to counter fertility issues in humans.
View companyAnnexon Biosciences
HQ
Brisbane, US
Employees
100↑ 41% increase
Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
View company